Pharma & Healthcare
Global Human Chorionic Gonadotrophin (HCG) Market Research Report 2025
- Mar 11, 25
- ID: 31523
- Pages: 60
- Figures: 60
- Views: 14
The global market for Human Chorionic Gonadotrophin (HCG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Human Chorionic Gonadotrophin (HCG) is a hormone produced during pregnancy. It is used as an indicator in pregnancy tests and can also be administered medically for various purposes.
North American market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Human Chorionic Gonadotrophin (HCG) in Drug is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Human Chorionic Gonadotrophin (HCG) include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd., Shanghai Tianwei Biopharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotrophin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotrophin (HCG).
The Human Chorionic Gonadotrophin (HCG) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Chorionic Gonadotrophin (HCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Chorionic Gonadotrophin (HCG) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Segment by Type
u-hCG
r-hCG
Segment by Application
Drug
Pregnancy Test Paper
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Chorionic Gonadotrophin (HCG) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human Chorionic Gonadotrophin (HCG) is a hormone produced during pregnancy. It is used as an indicator in pregnancy tests and can also be administered medically for various purposes.
North American market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Chorionic Gonadotrophin (HCG) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Human Chorionic Gonadotrophin (HCG) in Drug is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Human Chorionic Gonadotrophin (HCG) include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd., Shanghai Tianwei Biopharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotrophin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotrophin (HCG).
The Human Chorionic Gonadotrophin (HCG) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Chorionic Gonadotrophin (HCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Chorionic Gonadotrophin (HCG) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Segment by Type
u-hCG
r-hCG
Segment by Application
Drug
Pregnancy Test Paper
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Chorionic Gonadotrophin (HCG) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 u-hCG
1.2.3 r-hCG
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotrophin (HCG) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug
1.3.3 Pregnancy Test Paper
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Chorionic Gonadotrophin (HCG) Market Perspective (2020-2031)
2.2 Global Human Chorionic Gonadotrophin (HCG) Growth Trends by Region
2.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Chorionic Gonadotrophin (HCG) Historic Market Size by Region (2020-2025)
2.2.3 Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2026-2031)
2.3 Human Chorionic Gonadotrophin (HCG) Market Dynamics
2.3.1 Human Chorionic Gonadotrophin (HCG) Industry Trends
2.3.2 Human Chorionic Gonadotrophin (HCG) Market Drivers
2.3.3 Human Chorionic Gonadotrophin (HCG) Market Challenges
2.3.4 Human Chorionic Gonadotrophin (HCG) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue (2020-2025)
3.1.2 Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Players (2020-2025)
3.2 Global Human Chorionic Gonadotrophin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Chorionic Gonadotrophin (HCG) Revenue
3.4 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotrophin (HCG) Revenue in 2024
3.5 Global Key Players of Human Chorionic Gonadotrophin (HCG) Head office and Area Served
3.6 Global Key Players of Human Chorionic Gonadotrophin (HCG), Product and Application
3.7 Global Key Players of Human Chorionic Gonadotrophin (HCG), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Type
4.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Type (2020-2025)
4.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2026-2031)
5 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Application
5.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Application (2020-2025)
5.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
6.2 North America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
6.4 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
7.2 Europe Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
7.4 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
8.2 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
9.2 Latin America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
9.4 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
10.2 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
11.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Details
11.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
11.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
11.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
11.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Details
11.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
11.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
11.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
11.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Details
11.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
11.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
11.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
11.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Details
11.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
11.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 u-hCG
1.2.3 r-hCG
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotrophin (HCG) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug
1.3.3 Pregnancy Test Paper
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Chorionic Gonadotrophin (HCG) Market Perspective (2020-2031)
2.2 Global Human Chorionic Gonadotrophin (HCG) Growth Trends by Region
2.2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Chorionic Gonadotrophin (HCG) Historic Market Size by Region (2020-2025)
2.2.3 Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2026-2031)
2.3 Human Chorionic Gonadotrophin (HCG) Market Dynamics
2.3.1 Human Chorionic Gonadotrophin (HCG) Industry Trends
2.3.2 Human Chorionic Gonadotrophin (HCG) Market Drivers
2.3.3 Human Chorionic Gonadotrophin (HCG) Market Challenges
2.3.4 Human Chorionic Gonadotrophin (HCG) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue
3.1.1 Global Top Human Chorionic Gonadotrophin (HCG) Players by Revenue (2020-2025)
3.1.2 Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Players (2020-2025)
3.2 Global Human Chorionic Gonadotrophin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Chorionic Gonadotrophin (HCG) Revenue
3.4 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio
3.4.1 Global Human Chorionic Gonadotrophin (HCG) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotrophin (HCG) Revenue in 2024
3.5 Global Key Players of Human Chorionic Gonadotrophin (HCG) Head office and Area Served
3.6 Global Key Players of Human Chorionic Gonadotrophin (HCG), Product and Application
3.7 Global Key Players of Human Chorionic Gonadotrophin (HCG), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Type
4.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Type (2020-2025)
4.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2026-2031)
5 Human Chorionic Gonadotrophin (HCG) Breakdown Data by Application
5.1 Global Human Chorionic Gonadotrophin (HCG) Historic Market Size by Application (2020-2025)
5.2 Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
6.2 North America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
6.4 North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
7.2 Europe Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
7.4 Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
8.2 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
9.2 Latin America Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
9.4 Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size (2020-2031)
10.2 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
11.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Details
11.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
11.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
11.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
11.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Details
11.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
11.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
11.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
11.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Details
11.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
11.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
11.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
11.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Details
11.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
11.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Introduction
11.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
11.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of u-hCG
Table 3. Key Players of r-hCG
Table 4. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2020-2025)
Table 8. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2026-2031)
Table 10. Human Chorionic Gonadotrophin (HCG) Market Trends
Table 11. Human Chorionic Gonadotrophin (HCG) Market Drivers
Table 12. Human Chorionic Gonadotrophin (HCG) Market Challenges
Table 13. Human Chorionic Gonadotrophin (HCG) Market Restraints
Table 14. Global Human Chorionic Gonadotrophin (HCG) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players (2020-2025)
Table 16. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2024)
Table 17. Ranking of Global Top Human Chorionic Gonadotrophin (HCG) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Chorionic Gonadotrophin (HCG), Headquarters and Area Served
Table 20. Global Key Players of Human Chorionic Gonadotrophin (HCG), Product and Application
Table 21. Global Key Players of Human Chorionic Gonadotrophin (HCG), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotrophin (HCG) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2020-2025)
Table 25. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2026-2031)
Table 27. Global Human Chorionic Gonadotrophin (HCG) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2020-2025)
Table 29. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2026-2031)
Table 31. North America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Details
Table 47. Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
Table 48. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 49. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 50. Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
Table 51. Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Details
Table 52. Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
Table 53. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 54. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 55. Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
Table 56. Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Details
Table 57. Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
Table 58. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 59. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 60. Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
Table 61. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Details
Table 62. Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
Table 63. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 64. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 65. Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Human Chorionic Gonadotrophin (HCG) Picture
Figure 2. Global Human Chorionic Gonadotrophin (HCG) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Chorionic Gonadotrophin (HCG) Market Share by Type: 2024 VS 2031
Figure 4. u-hCG Features
Figure 5. r-hCG Features
Figure 6. Global Human Chorionic Gonadotrophin (HCG) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Chorionic Gonadotrophin (HCG) Market Share by Application: 2024 VS 2031
Figure 8. Drug Case Studies
Figure 9. Pregnancy Test Paper Case Studies
Figure 10. Other Case Studies
Figure 11. Human Chorionic Gonadotrophin (HCG) Report Years Considered
Figure 12. Global Human Chorionic Gonadotrophin (HCG) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Human Chorionic Gonadotrophin (HCG) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region: 2024 VS 2031
Figure 15. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players in 2024
Figure 16. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue in 2024
Figure 18. North America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 20. United States Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 24. Germany Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Share by Region (2020-2031)
Figure 32. China Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 40. Mexico Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 44. Turkey Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 48. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 49. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 50. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of u-hCG
Table 3. Key Players of r-hCG
Table 4. Global Human Chorionic Gonadotrophin (HCG) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2020-2025)
Table 8. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region (2026-2031)
Table 10. Human Chorionic Gonadotrophin (HCG) Market Trends
Table 11. Human Chorionic Gonadotrophin (HCG) Market Drivers
Table 12. Human Chorionic Gonadotrophin (HCG) Market Challenges
Table 13. Human Chorionic Gonadotrophin (HCG) Market Restraints
Table 14. Global Human Chorionic Gonadotrophin (HCG) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players (2020-2025)
Table 16. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2024)
Table 17. Ranking of Global Top Human Chorionic Gonadotrophin (HCG) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Chorionic Gonadotrophin (HCG), Headquarters and Area Served
Table 20. Global Key Players of Human Chorionic Gonadotrophin (HCG), Product and Application
Table 21. Global Key Players of Human Chorionic Gonadotrophin (HCG), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Chorionic Gonadotrophin (HCG) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2020-2025)
Table 25. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Type (2026-2031)
Table 27. Global Human Chorionic Gonadotrophin (HCG) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2020-2025)
Table 29. Global Human Chorionic Gonadotrophin (HCG) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share by Application (2026-2031)
Table 31. North America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Details
Table 47. Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
Table 48. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 49. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 50. Qingdao Kangyuan Pharmaceutical Co., Ltd. Recent Development
Table 51. Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Details
Table 52. Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
Table 53. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 54. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 55. Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Development
Table 56. Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Details
Table 57. Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
Table 58. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 59. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 60. Jiangxi Haoran Biopharmaceutical Co., Ltd. Recent Development
Table 61. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Details
Table 62. Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
Table 63. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product
Table 64. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue in Human Chorionic Gonadotrophin (HCG) Business (2020-2025) & (US$ Million)
Table 65. Shanghai Tianwei Biopharmaceutical Co., Ltd. Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Human Chorionic Gonadotrophin (HCG) Picture
Figure 2. Global Human Chorionic Gonadotrophin (HCG) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Chorionic Gonadotrophin (HCG) Market Share by Type: 2024 VS 2031
Figure 4. u-hCG Features
Figure 5. r-hCG Features
Figure 6. Global Human Chorionic Gonadotrophin (HCG) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Chorionic Gonadotrophin (HCG) Market Share by Application: 2024 VS 2031
Figure 8. Drug Case Studies
Figure 9. Pregnancy Test Paper Case Studies
Figure 10. Other Case Studies
Figure 11. Human Chorionic Gonadotrophin (HCG) Report Years Considered
Figure 12. Global Human Chorionic Gonadotrophin (HCG) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Human Chorionic Gonadotrophin (HCG) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Chorionic Gonadotrophin (HCG) Market Share by Region: 2024 VS 2031
Figure 15. Global Human Chorionic Gonadotrophin (HCG) Market Share by Players in 2024
Figure 16. Global Top Human Chorionic Gonadotrophin (HCG) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotrophin (HCG) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue in 2024
Figure 18. North America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 20. United States Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 24. Germany Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Human Chorionic Gonadotrophin (HCG) Market Share by Region (2020-2031)
Figure 32. China Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 40. Mexico Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Human Chorionic Gonadotrophin (HCG) Market Share by Country (2020-2031)
Figure 44. Turkey Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Human Chorionic Gonadotrophin (HCG) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Qingdao Kangyuan Pharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 48. Ningbo Renjian Pharmaceutical Group Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 49. Jiangxi Haoran Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 50. Shanghai Tianwei Biopharmaceutical Co., Ltd. Revenue Growth Rate in Human Chorionic Gonadotrophin (HCG) Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232